ELANE and myelodysplastic syndrome: One possible explanation of leukemic risk among ELANE carriers is an increased ROS level induced by misfolded proteins leads to oxidative damage, which may be responsible for 2nd hits and initiates malignant transformation, so AML or MDS development.